Search research articles
Contact Us
Filters
Showing results (631-640 of 736) with videos related to
Page
of 74
Sort By:
The American Journal of Gastroenterology
|
May 29, 2019
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience
Vincenza Calvaruso, Irene Cacciola, Anna Licata, et al.
Journal of Hepatology
|
February 14, 2017
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma
Giuseppe Cabibbo, Salvatore Petta, Marco Barbara, et al.
British Journal of Cancer
|
November 23, 2006
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
L L Villa, R L R Costa, C A Petta, et al.
JHEP Reports : Innovation in Hepatology
|
August 4, 2023
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease
Grazia Pennisi, Marco Enea, Mauro Viganò, et al.
Journal of Hepatology
|
June 6, 2021
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
Ramy Younes, Gian Paolo Caviglia, Olivier Govaere, et al.
Journal of Hepatology
|
April 9, 2019
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
Giuseppe Cabibbo, Ciro Celsa, Vincenza Calvaruso, et al.
Journal of Hepatology
|
April 17, 2020
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort<sup>☆</sup>
Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
Alimentary Pharmacology & Therapeutics
|
October 30, 2016
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
S Petta, G Cabibbo, M Barbara, et al.
Gastroenterology
|
April 16, 2018
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
Vincenza Calvaruso, Giuseppe Cabibbo, Irene Cacciola, et al.
Journal of Hepatology
|
June 11, 2018
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes, Quentin M Anstee, Maria Teresa Arias-Loste, et al.
Page
of 74
Search research articles
Search
Showing results (631-640 of 736) with videos related to
Sort By:
Page
of 74
The American Journal of Gastroenterology
|
May 29, 2019
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience
Vincenza Calvaruso, Irene Cacciola, Anna Licata, et al.
Journal of Hepatology
|
February 14, 2017
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma
Giuseppe Cabibbo, Salvatore Petta, Marco Barbara, et al.
British Journal of Cancer
|
November 23, 2006
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
L L Villa, R L R Costa, C A Petta, et al.
JHEP Reports : Innovation in Hepatology
|
August 4, 2023
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease
Grazia Pennisi, Marco Enea, Mauro Viganò, et al.
Journal of Hepatology
|
June 6, 2021
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
Ramy Younes, Gian Paolo Caviglia, Olivier Govaere, et al.
Journal of Hepatology
|
April 9, 2019
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
Giuseppe Cabibbo, Ciro Celsa, Vincenza Calvaruso, et al.
Journal of Hepatology
|
April 17, 2020
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort<sup>☆</sup>
Quentin M Anstee, Rebecca Darlay, Simon Cockell, et al.
Alimentary Pharmacology & Therapeutics
|
October 30, 2016
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
S Petta, G Cabibbo, M Barbara, et al.
Gastroenterology
|
April 16, 2018
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
Vincenza Calvaruso, Giuseppe Cabibbo, Irene Cacciola, et al.
Journal of Hepatology
|
June 11, 2018
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes, Quentin M Anstee, Maria Teresa Arias-Loste, et al.
Page
of 74